 Voyager Therapeutics Inc NASDAQ: VYGR has announced licensing option agreement with Pfizer Inc NYSE: PFE for capsids generated from Voyagers RNA-driven TRACER screening technology. Related: Voyager CEO Resigns After Company Turns Back To Discovery-Stage 